Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province

ObjectiveTo investigate the specific anti-SARS-CoV-2 antibody in adults and above after initial vaccination with inactivated COVID-19 vaccine, and determine the influencing factors.MethodsIn this study, residents aged 18 and above who had completed two doses of inactivated COVID-19 vaccine in Deqing...

Full description

Bibliographic Details
Main Authors: MAO Chuanwu, CHEN Yingfeng, ZHANG Li, XIE Yuyang, DONG Xiaolian, JIANG Lufang, JIANG Qingwu
Format: Article
Language:zho
Published: Shanghai Preventive Medicine Association 2022-11-01
Series:Shanghai yufang yixue
Subjects:
Online Access:http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.22105
_version_ 1797939254263808000
author MAO Chuanwu
CHEN Yingfeng
ZHANG Li
XIE Yuyang
DONG Xiaolian
JIANG Lufang
JIANG Qingwu
author_facet MAO Chuanwu
CHEN Yingfeng
ZHANG Li
XIE Yuyang
DONG Xiaolian
JIANG Lufang
JIANG Qingwu
author_sort MAO Chuanwu
collection DOAJ
description ObjectiveTo investigate the specific anti-SARS-CoV-2 antibody in adults and above after initial vaccination with inactivated COVID-19 vaccine, and determine the influencing factors.MethodsIn this study, residents aged 18 and above who had completed two doses of inactivated COVID-19 vaccine in Deqing County, Huzhou City, Zhejiang Province were included. Information such as gender, age, type of vaccine and vaccination time were collected, and serum specimens were sampled. Anti-SARS-CoV-2 receptor binding domain (RBD) antibody was quantitatively examined by enzyma-linked immunosorbent assay (ELISA) and influencing factors were determined.ResultsThe median concentration of anti-SARS-CoV-2 IgG antibody in the residents vaccinated with an inactivated booster vaccine was higher than that in those vaccinated with only two doses of COVID-19 vaccine or single dose (P<0.05). The median concentration of IgG antibody in males was 9.73 (4.01‒23.70) RU‧mL-1, lower than 17.76 (7.07‒49.23) RU‧mL-1 in females (P<0.05). The median concentration in the residents vaccinated with BBIBP-CorV (Sinopharm) was 6.53 (0.97‒13.69) RU‧mL-1, which was lower than that in those vaccinated with CoronaVac (Sinovac) that was 17.29 (8.54‒43.73) RU‧mL-1 (P<0.05). The median concentration in those with BBIBP-CorV was also lower than 12 (5.45‒40.06) RU‧mL-1 in those with heterologous booster vaccine (P<0.05). The median concentration was 9.73 (3.83‒23.63) RU‧mL-1 in the residents with an interval of more than 6 months from the second dose, which was lower than 14.66 (6.36‒35.98) RU‧mL-1 in those with an interval of 3‒6 months (P<0.05). Moreover, immune effect was better in females (χ²=16.464, P<0.05), 18‒45 years (χ²=7.158, P<0.05), and those vaccinated with CornaVac (χ²=49.637, P<0.05), while decreased in those with an interval of more than 6 months from the second dose (χ²=8.447, P<0.05).ConclusionGender, age, and type of vaccine may affect the effect of immunization. The COVID-19 vaccination shows an acceptable immunogenicity in adults; however, it declines in 6 months after vaccination. It warrants strengthening the booster vaccination to maintain the immune response.
first_indexed 2024-04-10T19:12:29Z
format Article
id doaj.art-acfd205a630a4bf984f1d07c09e1c1f5
institution Directory Open Access Journal
issn 1004-9231
language zho
last_indexed 2024-04-10T19:12:29Z
publishDate 2022-11-01
publisher Shanghai Preventive Medicine Association
record_format Article
series Shanghai yufang yixue
spelling doaj.art-acfd205a630a4bf984f1d07c09e1c1f52023-01-30T10:54:17ZzhoShanghai Preventive Medicine AssociationShanghai yufang yixue1004-92312022-11-0134111118112210.19428/j.cnki.sjpm.2022.221051004-9231(2022)11-1118-05Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang ProvinceMAO Chuanwu0CHEN Yingfeng1ZHANG Li2XIE Yuyang3DONG Xiaolian4JIANG Lufang5JIANG Qingwu6School of Public Health, Fudan University, Shanghai 200032, ChinaDeqing County Center for Disease Control and Prevention, Huzhou Zhejiang 313200, ChinaSchool of Public Health, Fudan University, Shanghai 200032, ChinaDeqing County Center for Disease Control and Prevention, Huzhou Zhejiang 313200, ChinaDeqing County Center for Disease Control and Prevention, Huzhou Zhejiang 313200, ChinaSchool of Public Health, Fudan University, Shanghai 200032, ChinaSchool of Public Health, Fudan University, Shanghai 200032, ChinaObjectiveTo investigate the specific anti-SARS-CoV-2 antibody in adults and above after initial vaccination with inactivated COVID-19 vaccine, and determine the influencing factors.MethodsIn this study, residents aged 18 and above who had completed two doses of inactivated COVID-19 vaccine in Deqing County, Huzhou City, Zhejiang Province were included. Information such as gender, age, type of vaccine and vaccination time were collected, and serum specimens were sampled. Anti-SARS-CoV-2 receptor binding domain (RBD) antibody was quantitatively examined by enzyma-linked immunosorbent assay (ELISA) and influencing factors were determined.ResultsThe median concentration of anti-SARS-CoV-2 IgG antibody in the residents vaccinated with an inactivated booster vaccine was higher than that in those vaccinated with only two doses of COVID-19 vaccine or single dose (P<0.05). The median concentration of IgG antibody in males was 9.73 (4.01‒23.70) RU‧mL-1, lower than 17.76 (7.07‒49.23) RU‧mL-1 in females (P<0.05). The median concentration in the residents vaccinated with BBIBP-CorV (Sinopharm) was 6.53 (0.97‒13.69) RU‧mL-1, which was lower than that in those vaccinated with CoronaVac (Sinovac) that was 17.29 (8.54‒43.73) RU‧mL-1 (P<0.05). The median concentration in those with BBIBP-CorV was also lower than 12 (5.45‒40.06) RU‧mL-1 in those with heterologous booster vaccine (P<0.05). The median concentration was 9.73 (3.83‒23.63) RU‧mL-1 in the residents with an interval of more than 6 months from the second dose, which was lower than 14.66 (6.36‒35.98) RU‧mL-1 in those with an interval of 3‒6 months (P<0.05). Moreover, immune effect was better in females (χ²=16.464, P<0.05), 18‒45 years (χ²=7.158, P<0.05), and those vaccinated with CornaVac (χ²=49.637, P<0.05), while decreased in those with an interval of more than 6 months from the second dose (χ²=8.447, P<0.05).ConclusionGender, age, and type of vaccine may affect the effect of immunization. The COVID-19 vaccination shows an acceptable immunogenicity in adults; however, it declines in 6 months after vaccination. It warrants strengthening the booster vaccination to maintain the immune response.http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.22105covid-19 vaccineanti-sars-cov-2 receptor binding domain igg antibodyimmune effectserological evaluation
spellingShingle MAO Chuanwu
CHEN Yingfeng
ZHANG Li
XIE Yuyang
DONG Xiaolian
JIANG Lufang
JIANG Qingwu
Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
Shanghai yufang yixue
covid-19 vaccine
anti-sars-cov-2 receptor binding domain igg antibody
immune effect
serological evaluation
title Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
title_full Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
title_fullStr Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
title_full_unstemmed Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
title_short Serological evaluation of immune effect of inactivated COVID-19 vaccine in adult population in Deqing County, Huzhou City, Zhejiang Province
title_sort serological evaluation of immune effect of inactivated covid 19 vaccine in adult population in deqing county huzhou city zhejiang province
topic covid-19 vaccine
anti-sars-cov-2 receptor binding domain igg antibody
immune effect
serological evaluation
url http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.22105
work_keys_str_mv AT maochuanwu serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT chenyingfeng serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT zhangli serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT xieyuyang serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT dongxiaolian serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT jianglufang serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince
AT jiangqingwu serologicalevaluationofimmuneeffectofinactivatedcovid19vaccineinadultpopulationindeqingcountyhuzhoucityzhejiangprovince